Autoimmune disease is a condition in which the body responds to the autoantigens and causes damage to its own tissues. We conducted this research to investigate whether interleukin-23R (IL-23R) gene polymorphisms (rs11209026 A/G) are related to the risk of several common autoimmune diseases like rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriasis. We screened articles about rs11209026 A/G for autoimmune disease by China Knowledge Infrastructure Project (CNKI), Web of Science as well as PubMed databases. The correlation strength was expressed by odds ratio (OR) and 95% confidence interval, and the trial sequential analysis (TSA) proved the reliability of the results. Generally, 33 studies were contained. There was a significant correlation between rs11209026 A/G polymorphism and the susceptibility of human autoimmune diseases (OR = 0.78, 95% CI = 0.65–0.94, p < 0.05). In addition, allele A was associated with AS (OR = 0.61, 95% CI = 0.55–0.68, p < 0.05) and psoriasis (OR = 0.51, 95% CI = 0.34–0.77, p < 0.05), but not RA (p > 0.05). In ethnic subgroup analysis, AA genotype could reduce the risk of AS in Caucasian people (OR = 0.46, 95% CI = 0.25–0.87, p < 0.05), and in the results of dominant gene model analysis, AA + GA has statistical significance in reducing the risk of autoimmune diseases (OR = 0.69, 95% CI = 0.56–0.84, p < 0.05). Meta-analysis showed that IL-23R gene polymorphism (rs11209026 A/G) is associated with AS, RA and Psoriasis and allele A is a protective factor, especially in Caucasian population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.